Intellia Therapeutics Inc Stock Forecast

Buy or Hold candidate since May 08, 2025 Gain 3.26%

The Intellia Therapeutics Inc stock price gained 5.30% on the last trading day (Monday, 12th May 2025), rising from $8.12 to $8.55. During the last trading day the stock fluctuated 5.96% from a day low at $8.39 to a day high of $8.89. The price has been going up and down for this period, and there has been a 0.83% gain for the last 2 weeks. Volume fell on the last day by -651 thousand shares and in total, 4 million shares were bought and sold for approximately $32.25 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $8.80 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -29.36% during the next 3 months and, with a 90% probability hold a price between $3.45 and $6.22 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

NTLA Signals & Forecast

There are mixed signals in the stock today. A sell signal was issued from a pivot top point on Wednesday, April 30, 2025, and so far it has fallen -3.61%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). The Intellia Therapeutics Inc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $8.11 and $7.78. A breakdown below any of these levels will issue sell signals. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss for Intellia Therapeutics Inc stock

Intellia Therapeutics Inc finds support from accumulated volume at $8.31 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.500 between high and low, or 5.96%. For the last week, the stock has had daily average volatility of 9.83%.

Our recommended stop-loss: $8.18 (-4.33%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 8 days ago.)

Trading Expectations (NTLA) For The Upcoming Trading Day Of Tuesday 13th

For the upcoming trading day on Tuesday, 13th we expect Intellia Therapeutics Inc to open at $8.61, and during the day (based on 14 day Average True Range), to move between $7.84 and $9.26, which gives a possible trading interval of +/-$0.707 (+/-8.27%) up or down from last closing price. If Intellia Therapeutics Inc takes out the full calculated possible swing range there will be an estimated 16.53% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $8.31 (2.81%) than the resistance at $9.10 (6.37%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Intellia Therapeutics Inc stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.

Current score: 1.684 Buy Candidate Upgraded

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

Predicted Fair Opening Price

Predicted fair opening price on May 13, 2025 - $8.61 ( 0.702%).